A carregar...

Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine

BACKGROUND: Currently licensed human vaccines are subtype-specific and do not protect against pandemic H5N1 viruses. Previously, our group has reported on the construction of an influenza virus-like particle (VLP) as a new generation candidate vaccine. A mixture of influenza H5N1 VLPs representing c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Crevar, Corey J, Ross, Ted M
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2583969/
https://ncbi.nlm.nih.gov/pubmed/18957098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-422X-5-131
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!